News on immunohistochemistry and other tissue-based testing methods.
The companies will work with collaborators at Stockholm University to integrate their respective technologies for in situ sequencing and tissue processing.
The assay examine phenotypic behaviors of isolated cancer cells from biopsies at initial diagnosis.
Kiyatec's cell-based assays model and predict patient therapeutic response to drive cancer drug development and potentially guide treatment.
The planned product would combine RNA assays for NanoString's GeoMx digital spatial profiling instrument with Bio-Techne's RNAscope imaging reagents.
The partnership will accelerate the development of molecular diagnostics in the Chinese market, Minneapolis-based Bio-Techne said.
